Difference between revisions of "LncRNAWiki:Prostate-cancer"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !width="50"|Name !width="50"|Transcript ID !width="50"|Alias !width="50"|Description !width="50"|Disease |-...") |
|||
| Line 192: | Line 192: | ||
|"downregulated RNA in cancer, inhibitor of cell invasion and migration" | |"downregulated RNA in cancer, inhibitor of cell invasion and migration" | ||
|prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma | |prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma | ||
| + | |- | ||
| + | |''HCG11'' | ||
| + | |[[HCG11]] | ||
| + | |bK14H9.3, FLJ14049, FLJ30357 | ||
| + | |HLA complex group 11 (non-protein coding) | ||
| + | |prostate cancer | ||
| + | |- | ||
| + | |''LINC01138'' | ||
| + | |[[LINC01138]] | ||
| + | |LINC00875, FLJ39739 | ||
| + | |long intergenic non-protein coding RNA 1138 | ||
| + | |prostate cancer | ||
| + | |- | ||
| + | |''LINC01116'' | ||
| + | |[[LINC01116]] | ||
| + | |TALNEC2 | ||
| + | |long intergenic non-protein coding RNA 1116 | ||
| + | |prostate cancer, GBM | ||
|} | |} | ||
Latest revision as of 08:58, 28 June 2017
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| CDKN2B-AS1 | NONHSAT130421,lnc-C9orf53-2:1 | ANRIL, p15AS, ENSG00000240498 | CDKN2B antisense RNA 1 | prostate cancer |
| MALAT1 | ENST00000534336.1 | HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2", "nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | prostate cancer |
| GAS5 | NONHSAT007663 | SNHG2, ENSG00000234741 | _ | autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus |
| H19 | NONHSAT017465 | Q96MK8,ENSG00000130600 | "H19, imprinted maternally expressed transcript (non-protein coding)" | bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor |
| MEG3 | NONHSAT039745 | Gtl2, ENSG00000214548 | maternally expressed 3 (non-protein coding) | prostate-cancer |
| PVT1 | ENST00000513868.2 | NCRNA00079, LINC00079, onco-lncRNA-100 | Pvt1 oncogene (non-protein coding) | breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer |
| IGF2-AS | IGF2-AS | "PEG8, IGF2-AS1" | IGF2 antisense RNA | hepatocelluar carcinoma,prostate cancer, type 1 diabetes, Wilms' tumor |
| TRPM2-AS | TRPM2-AS | TRPM2-AS1 | TRPM2 antisense RNA | prostate-cancer |
| PCAT18 | PCAT18 | LINC01092 | prostate cancer associated transcript 18 (non-protein coding) | metastatic prostate cancer |
| PCA3 | ENST00000412654.1 | DD3, NCRNA00019, PCAT3 | prostate cancer associated 3 (non-protein coding) | prostate Cancer |
| PCAT1 | ENST00000561978.1 | "PCAT-1, PCA1" | prostate cancer associated transcript 1 (non-protein coding) | prostate Cancer |
| PCAT4 | ENST00000504263.1 | "GDEP, PCAN1, PCA4" | prostate cancer associated transcript 4 (non-protein coding) | prostate Cancer |
| PCAT7 | ENST00000452148.2 | PCAN-R2 | prostate cancer associated transcript 7 (non-protein coding) | prostate Cancer |
| PRNCR1 | NONHSAT129019 | N/A | prostate cancer associated non-coding RNA 1 | Prostate Cancer |
| SCHLAP1 | NONHSAT075852 | SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding) | "SChLAP1,PCAT11" | prostate cancer |
| PCGEM1 | NONHSAT076153 | ENSG00000227418, PCAT9; LINC00071, NCRNA00071 lncRNA | Prostate-specific transcript 1 | prostate-cancer |
| PTENP1 | NONHSAT130775 | "PTENpg1, PTEN2, ENSG00000237984" | PTEN Pseudogene 1 | prostate-cancer |
| PCAT6 | ENST00000425295.1,ENST00000553157.1,ENST00000417262.1 | "Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1)", ENSG00000228288 | N/A | prostate cancer |
| C1QTNF9B-AS1 | C1QTNF9B-AS1 | PCOTH | C1QTNF9B antisense RNA 1 | prostate cancer |
| CASC19 | CASC19 | CARLo-6 | cancer susceptibility candidate 19 (non-protein coding) | prostate cancer |
| CTBP1-AS | CTBP1-AS | PCAT10 | CTBP1 antisense RNA | prostate cancer |
| LINC00963 | LINC00963 | N/A | long intergenic non-protein coding RNA 963 | prostate cancer |
| PCAT14 | PCAT14 | N/A | prostate cancer associated transcript 14 (non-protein coding) | prostate cancer |
| PCAT19 | PCAT19 | LINC01190 | prostate cancer associated transcript 19 (non-protein coding) | prostate cancer |
| PCAT29 | PCAT29 | N/A | prostate cancer associated transcript 29 (non-protein coding) | prostate cancer |
| PCAT5 | PCAT5 | TPCAT-10-36067 | prostate cancer associated transcript 5 (non-protein coding) | Prostate Cancer |
| SOCS2-AS1 | SOCS2-AS1 | N/A | SOCS2 antisense RNA 1 | prostate-cancer |
| LINC00272 | LINC00272 | RP1-223H12.3 | long intergenic non-protein coding RNA 272 | prostate cancer region |
| TTTY15 | TTTY15 | DKFZP434I143, NCRNA00138 | "testis-specific transcript, Y-linked 15 (non-protein coding)" | prostate cancer sample |
| PART1 | ENST00000506884.1 | DKFZP586D0823, NCRNA00206 | prostate androgen-regulated transcript 1 (non-protein coding) | prostate carcinogenesis |
| DRAIC | DRAIC | N/A | "downregulated RNA in cancer, inhibitor of cell invasion and migration" | prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma |
| HCG11 | HCG11 | bK14H9.3, FLJ14049, FLJ30357 | HLA complex group 11 (non-protein coding) | prostate cancer |
| LINC01138 | LINC01138 | LINC00875, FLJ39739 | long intergenic non-protein coding RNA 1138 | prostate cancer |
| LINC01116 | LINC01116 | TALNEC2 | long intergenic non-protein coding RNA 1116 | prostate cancer, GBM |
